06 4月 2021 by admin in UncategorizedComments Arcellx Announces FDA Clearance of IND Application for ACLX-001, a Controllable Cell Therapy Utilizing the Company’s ARC-SparX Platform, for the Treatment of Multiple Myeloma
30 3月 2021 by admin in UncategorizedComments Design Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters
26 3月 2021 by admin in UncategorizedComments Design Therapeutics Announces Pricing of Initial Public Offering
22 3月 2021 by admin in UncategorizedComments Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing
11 3月 2021 by admin in UncategorizedComments Adicet Reports Fourth Quarter and Full Year 2020 Financial results
10 3月 2021 by admin in UncategorizedComments Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for the Treatment of B
04 3月 2021 by admin in UncategorizedComments Syros Reports Fourth Quarter and Full Year 2020 Financial Results
04 3月 2021 by admin in UncategorizedComments NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial
03 3月 2021 by admin in UncategorizedComments Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
02 3月 2021 by admin in UncategorizedComments Innoforce and dMed Collaborate to Accelerate the Development of Innovative Therapeutics
16 2月 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private
10 2月 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent
09 2月 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private
26 1月 2021 by admin in UncategorizedComments Arcellx Appoints Rami Elghandour as Chairman and Chief Executive Officer
14 1月 2021 by admin in UncategorizedComments Dr. Han Myint Appointed as NextCure’s Chief Medical Officer
11 1月 2021 by admin in UncategorizedComments Syros Announces Strategic Priorities and Expected Milestones
07 1月 2021 by admin in UncategorizedComments 科越医药宣布获得 5350 万美元的 B+轮 1 期 融资 (first closing)，以推进 LOGIC 药物发现平台和补体靶向疗法
10 12月 2020 by admin in UncategorizedComments Crescendo Biologics Expands its Ongoing Collaboration with Takeda
07 12月 2020 by admin in UncategorizedComments Arcellx CART-ddBCMA Cell Therapy Demonstrates Deep and Durable Responses in the Treatment of Relapsed and Refractory Multiple Myeloma
01 12月 2020 by admin in UncategorizedComments Adicet Announces Appointment of Dr. Bastiano Sanna to its Board of Directors
05 11月 2020 by admin in UncategorizedComments Syros Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
